Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
OBJECTIVE: To evaluate open-label adalimumab therapy for clinical effectiveness, fistula healing, patient-reported outcomes and safety in Canadian patients with moderate to severe Crohn’s disease (CD) who were either naive to or previously exposed to antitumour necrosis factor (anti-TNF) therapy.
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2011/724813 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832568228810850304 |
|---|---|
| author | Remo Panaccione Edward V Loftus David Binion Kevin McHugh Shamsul Alam Naijun Chen Benoît Guérette Parvez Mulani Jingdong Chao |
| author_facet | Remo Panaccione Edward V Loftus David Binion Kevin McHugh Shamsul Alam Naijun Chen Benoît Guérette Parvez Mulani Jingdong Chao |
| author_sort | Remo Panaccione |
| collection | DOAJ |
| description | OBJECTIVE: To evaluate open-label adalimumab therapy for clinical effectiveness, fistula healing, patient-reported outcomes and safety in Canadian patients with moderate to severe Crohn’s disease (CD) who were either naive to or previously exposed to antitumour necrosis factor (anti-TNF) therapy. |
| format | Article |
| id | doaj-art-8fc99cce04214177a1efc118cfa7fc8f |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-8fc99cce04214177a1efc118cfa7fc8f2025-02-03T00:59:29ZengWileyCanadian Journal of Gastroenterology0835-79002011-01-0125841942510.1155/2011/724813Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) TrialRemo Panaccione0Edward V Loftus1David Binion2Kevin McHugh3Shamsul Alam4Naijun Chen5Benoît Guérette6Parvez Mulani7Jingdong Chao8University of Calgary, Calgary, Alberta, CanadaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USAUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USAAbbott Laboratories, Montreal, Quebec, CanadaAbbott Laboratories, Abbott Park, Illinois, USAAbbott Laboratories, Abbott Park, Illinois, USAAbbott Laboratories, Rungis, FranceAbbott Laboratories, Abbott Park, Illinois, USAAbbott Laboratories, Abbott Park, Illinois, USAOBJECTIVE: To evaluate open-label adalimumab therapy for clinical effectiveness, fistula healing, patient-reported outcomes and safety in Canadian patients with moderate to severe Crohn’s disease (CD) who were either naive to or previously exposed to antitumour necrosis factor (anti-TNF) therapy.http://dx.doi.org/10.1155/2011/724813 |
| spellingShingle | Remo Panaccione Edward V Loftus David Binion Kevin McHugh Shamsul Alam Naijun Chen Benoît Guérette Parvez Mulani Jingdong Chao Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial Canadian Journal of Gastroenterology |
| title | Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial |
| title_full | Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial |
| title_fullStr | Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial |
| title_full_unstemmed | Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial |
| title_short | Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial |
| title_sort | efficacy and safety of adalimumab in canadian patients with moderate to severe crohn s disease results of the adalimumab in canadian subjects with moderate to severe crohn s disease access trial |
| url | http://dx.doi.org/10.1155/2011/724813 |
| work_keys_str_mv | AT remopanaccione efficacyandsafetyofadalimumabincanadianpatientswithmoderatetoseverecrohnsdiseaseresultsoftheadalimumabincanadiansubjectswithmoderatetoseverecrohnsdiseaseaccesstrial AT edwardvloftus efficacyandsafetyofadalimumabincanadianpatientswithmoderatetoseverecrohnsdiseaseresultsoftheadalimumabincanadiansubjectswithmoderatetoseverecrohnsdiseaseaccesstrial AT davidbinion efficacyandsafetyofadalimumabincanadianpatientswithmoderatetoseverecrohnsdiseaseresultsoftheadalimumabincanadiansubjectswithmoderatetoseverecrohnsdiseaseaccesstrial AT kevinmchugh efficacyandsafetyofadalimumabincanadianpatientswithmoderatetoseverecrohnsdiseaseresultsoftheadalimumabincanadiansubjectswithmoderatetoseverecrohnsdiseaseaccesstrial AT shamsulalam efficacyandsafetyofadalimumabincanadianpatientswithmoderatetoseverecrohnsdiseaseresultsoftheadalimumabincanadiansubjectswithmoderatetoseverecrohnsdiseaseaccesstrial AT naijunchen efficacyandsafetyofadalimumabincanadianpatientswithmoderatetoseverecrohnsdiseaseresultsoftheadalimumabincanadiansubjectswithmoderatetoseverecrohnsdiseaseaccesstrial AT benoitguerette efficacyandsafetyofadalimumabincanadianpatientswithmoderatetoseverecrohnsdiseaseresultsoftheadalimumabincanadiansubjectswithmoderatetoseverecrohnsdiseaseaccesstrial AT parvezmulani efficacyandsafetyofadalimumabincanadianpatientswithmoderatetoseverecrohnsdiseaseresultsoftheadalimumabincanadiansubjectswithmoderatetoseverecrohnsdiseaseaccesstrial AT jingdongchao efficacyandsafetyofadalimumabincanadianpatientswithmoderatetoseverecrohnsdiseaseresultsoftheadalimumabincanadiansubjectswithmoderatetoseverecrohnsdiseaseaccesstrial |